Evaluation of the clinical effect of Bushenpingchuan granuleson on kidney deficiency of asthma
- Conditions
- asthma
- Registration Number
- ITMCTR2000003845
- Lead Sponsor
- Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Patients who meet the diagnosis and severity grade of bronchial asthma in the Guidelines for The Prevention and Treatment of Bronchial Asthma (2016 edition) formulated by the Asthma Group, Respiratory Division, Chinese Medical Association;
2. It conforms to the diagnosis of asthma of traditional Chinese medicine, and the syndrome differentiation of traditional Chinese medicine belongs to the deficiency of kidney;
3. Patients aged between 18 and 75 who voluntarily signed informed consent.
1. Grade 3 ~ 4 patients with acute onset or chronic duration of bronchial asthma;
2. Pulmonary infection, bronchiectasis, pulmonary heart disease, respiratory failure, pulmonary hypertension and other diseases;
3. Patients with severe diseases or mental diseases such as malignant tumors, cardiovascular and cerebrovascular diseases, liver and kidney diseases, hematopoietic diseases, diabetes, etc.;
4. Women planning pregnancy, pregnancy or breastfeeding;
5. Those who are known to be allergic to the ingredients of this drug;
6. Poor compliance and impaired speech and communication;
7. Patients participating in other clinical studies.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IL-6;TGF-beta;IL-17;
- Secondary Outcome Measures
Name Time Method